Medical Radiology and Radiation Safety. 2024. Vol. 69. № 1


Dmitry E. Kalinkin1, 2, Ivan V. Milto1, 2, Anas R. Takhauov1, Lilia R. Takhauova1, 2,
Yulia A. Samoilova3, Galina V. Gorina1, Olesya V. Litvinova1, Ravil M. Takhauov1, 2


The Sublimate Production Cohort of the Siberian Chemical Plant (Dosimetric Characteristics)

1 Seversk Biophysical Research Center, Seversk, Russia

2 Siberian State Medical University, Tomsk, Russia

3 Siberian Federal Scientific Clinical Center, Seversk, Russia

Contact person: Dmitry E. Kalinkin, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it.



Introduction: Uranium, which is the raw material basis of the nuclear industry, is capable of causing adverse medical and biological consequences for workers who come into contact with its compounds in the course of their professional activities. In order to study this effect and to study in detail the biomedical consequences of the effects of uranium compounds on the body of personnel of nuclear power facilities, it is necessary to form a cohort of persons engaged in work with uranium compounds. One of the key elements of the uranium conversion technology carried out within the framework of sublimation production is the production of raw uranium hexafluoride for subsequent isotopic enrichment.

Purpose: To form and characterize a cohort of sublimate production of the personnel of the Siberian Chemical Plant involved in work with uranium compounds in the period 1953–2000.

Material and methods: The source of information was the regional medical dosimetric register of Seversk Biophysical Research Center, containing information on all current and former employees of the Siberian Chemical Plant (about 65,000 people) from the moment of the company’s foundation to the present.

Results: A cohort of Siberian Chemical Plant workers involved in work with uranium compounds in the period 1953–2000 has been formed and described. The cohort consists of 577 people (475 men and 102 women). Biomedical information and dosimetric information about the employees included in the cohort are included in the created database of the personnel of the Siberian Chemical Plant involved in working with uranium compounds in the period 1953–2000.

Conclusion: The formed cohort and database will allow conducting epidemiological studies to assess the morbidity and mortality of personnel due to malignant neoplasms, as well as making scientifically sound conclusions about the role of uranium compounds in the occurrence and mortality due to malignant neoplasms.

Keywords: uranium compounds, personnel of radiation hazardous production, cohort formation, epidemiology

For citation: Kalinkin DE, Milto IV, Takhauov AR, Takhauova LR, Samoilova YA, Gorina GV, Litvinova OV, Takhauov RM. The Sublimate Production Cohort of the Siberian Chemical Plant (Dosimetric Characteristics). Medical Radiology and Radiation Safety. 2024;69(1):73–76. (In Russian). DOI:10.33266/1024-6177-2024-69-1-73-76



1. Surdyk S., Itani M., Al-Lobaidy M., Kahale L.A., Farha A., Dewachi O., Akl E.A., Habib R.R. Weaponised Uranium and Adverse Health Outcomes in Iraq: a Systematic Reviewю BMJ Glob. Health. 2021;6;2:e004166. DOI: 10.1136/bmjgh-2020-004166.

2. Tirmarche M., Apostoaei I., Blanchardon E., Ellis E.D., Gilbert E., Harrison J.D., Laurier D., Marsh J.W., Sokolnikov M., Wakeford R., Zhivin S. ICRP Publication 150: Cancer Risks from Plutonium and Uranium Exposure. Ann. ICRP. 2021;50;4:1–143. DOI: 10.1177/01466453211028020.

3. Tomasek L. Lung Cancer Lifetime Risks in Cohort Studies of Uranium Miners. Radiat. Prot. Dosimetry. 2020;191;2:171–175. DOI: 10.1093/rpd/ncaa143.

4. Thandra K.C., Barsouk A., Saginala K., Aluru J.S., Barsouk A. Epidemiology of Lung Cancer // Contemp Oncol (Pozn). 2021;25;1:45–52. DOI: 10.5114/wo.2021.103829.

5. Kelly-Reif K., Sandler D.P., Shore D., Schubauer-Berigan M.K., Troester M.A., Nylander-French L., Richardson D.B. Radon and Cancer Mortality among Underground Uranium Miners in the Příbram Region of the Czech Republic. Am. J. Ind. Med. 2020;63;10:859–867. DOI: 10.1002/ajim.23167. 

6. da Silva F.M.R. Júnior, Tavella R.A., Fernandes C.L.F., Dos Santos M. Genetic Damage in Coal and Uranium Miners. Mutat. Res. Genet. Toxicol. Environ Mutagen. 2021;866:503348. DOI: 10.1016/j.mrgentox.2021.503348.

7. Golden A.P., Milder C.M., Ellis E.D., Anderson J.L., Boice Jr J.D., Bertke S.J., Zablotska L.B. Cohort Profile: four Early Uranium Processing Facilities in the US and Canada. Int. J. Radiat. Biol. 2021;97;6:833–847. DOI: 10.1080/09553002.2021.1917786. 

8. Semenova Y., Pivina L., Zhunussov Y., Zhanaspayev M., Chirumbolo S., Muzdubayeva Z., Bjørklund G. Radiation-Related Health Hazards to Uranium Miners. Environ Sci. Pollut. Res. Int. 2020;27;28:34808–34822. DOI: 10.1007/s11356-020-09590-7.

9. Richardson D.B., Rage E., Demers P.A., Do M.T., Fenske N., Deffner V., Kreuzer M., Samet J., Bertke S.J., Kelly-Reif K., Schubauer-Berigan M.K., Tomasek L., Zablotska L.B., Wiggins C., Laurier D. Lung Cancer and Radon: Pooled Analysis of Uranium Miners Hired in 1960 or Later. Environ Health Perspect. 2022;130;5:57010. DOI: 10.1289/EHP10669. 

10. Rage E., Richardson D.B., Demers P.A., Do M.T., Fenske N., Kreuzer M., Samet J., Wiggins C., Schubauer-Berigan M.K., Kelly-Reif K., Tomasek L., Zablotska L.B., Laurier D. PUMA – Pooled Uranium Miners Analysis: Cohort Profile. Occup. Environ  Med. 2020;77;3:194–200. DOI: 10.1136/oemed-2019-105981.  



 PDF (RUS) Full-text article (in Russian)


Conflict of interest. The authors declare no conflict of interest.

Financing. The study was carried out within the framework of a state assignment, research topic “Assessment of the radiation situation and health status of personnel of the Siberian Chemical Plant involved in working with uranium compounds.”.

Contribution. Concept and design of the study: Kalinkin D.E., Milto I.V., Takhauov R.M.; data collection: Gorina G.V., Litvinova O.V., Samoilova Yu.A., Takhauov A.R., Takhauova L.R.; analysis and interpretation of results: Kalinkin D.E., Takhauov A.R.; literature review: Kalinkin D.E., Takhauova L.R.; preparation of the draft manuscript: Kalinkin D.E., Takhauov A.R., Milto I.V. All authors reviewed the results and approved the final version of the manuscript.

Article received: 20.10.2023. Accepted for publication: 27.11.2023.